Key Findings
The Global Biological Imaging Reagent market is predicted to rise at a CAGR of 7.91% over the forecast period of 2017- 2025. The key factors driving the market growth include the growing demand for imaging technologies, innovations for novel targeted imaging agents and imaging technologies, and the ease of accessibility for the pioneering laser eye medication.



Market Insights
The Global Biological Imaging reagent market is segmented based on the technology, modalities, end-users, class, end-use, and applications. The technological segment comprises of probes, small chemicals, radiotracers, micro bubbles, chelating molecules, fluorescent proteins, and nanoparticles. The market by modality is segmented into nuclear, optical, MRI, X-ray/CT, and ultrasound. The end-users for this market mainly comprise of diagnostics and research developments institutes. The market segment by class is further categorized according to the optical reagents, contrast reagents, and nuclear reagents. The end-use for the market can be used for in-vitro and in-vivo methodologies whereas the applications can be seen in contrast imaging, radioactive imaging, and optical imaging.
Regional Insights
The global biological imaging market is geographically spread throughout the North America, Asia-Pacific, Europe and rest of the world. Of these, the North American region dominated the global market in 2016, with the United States accounting for nearly 73% of the market share. This remarkable growth in the US can be credited to the increasing government funding for life science-based research, growing demand for GMO crops, and the booming pharmaceutical industry in the region. Over the forecast period, it is the rest of the world market (that comprises of countries like the Middle East, Africa, and Latin America) which is likely to be the fastest growing region for the global market.
Competitive Insights
PerkinElmer is a noted company in the market that provides products, services, and solutions focused on improving the health and safety of the people. Another important company, Bayer HealthCare Pharmaceuticals, is highly focused on developing and marketing therapeutic medicines for areas like oncology, gynecology, cardiology, ophthalmology, and hematology. The company operates in over 100 countries around the world. Some of the other well-known market players include Beckman-Coulter, Evident Technologies, Schering Ag, Bracco, GE Healthcare, Lantheus Medical Imaging, Jubilant Organosys, Life Technologies, and Siemens Medical.